Skip to main content
Premium Trial:

Request an Annual Quote

Genzyme Molecular, Silico Insights Co-Market Informatics, Gene Expression Systems

NEW YORK, June 24-Genzyme Molecular Oncology and Silico Insights will jointly market the SAGE gene expression system and the I-Sight Discovery informatics platform, the two companies said today.

 

The companies did not disclose financial details of the agreement.

 

The two companies are using the two systems together to identify tags and genes that may be useful in breast cancer diagnosis and treatment. Silico Insights is also analyzing GMO's tumor endothelial markers for potential applications in anti-angiogenesis.

 

Genzyme Molecular Oncology is a division of Genzyme. Its "serial analysis of gene expression" platform is licensed from Johns Hopkins University.

 

Silico Insights is an informatics company based in Woburn, Mass.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.